These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1030 related items for PubMed ID: 6432420

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Third generation cephalosporins.
    Donowitz GR.
    Infect Dis Clin North Am; 1989 Sep; 3(3):595-612. PubMed ID: 2671141
    [Abstract] [Full Text] [Related]

  • 3. [Review of oral cephalosporins. Basis for a rational choice].
    Forti IN.
    Medicina (B Aires); 1994 Sep; 54(5 Pt 1):439-58. PubMed ID: 7658980
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cefsulodin and ceftazidime, two antipseudomonal cephalosporins.
    Smith BR.
    Clin Pharm; 1984 Sep; 3(4):373-85. PubMed ID: 6380902
    [Abstract] [Full Text] [Related]

  • 8. Use of cephalosporins with enhanced anti-anaerobic activity for treatment and prevention of anaerobic and mixed infections.
    DiPiro JT, May JR.
    Clin Pharm; 1988 Apr; 7(4):285-302. PubMed ID: 3284692
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparative in vitro activities of third-generation cephalosporins.
    Fass RJ.
    Arch Intern Med; 1983 Sep; 143(9):1743-5. PubMed ID: 6615095
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The selection and use of cephalosporins: a review.
    Klein NC, Cunha BA.
    Adv Ther; 1995 Sep; 12(2):83-101. PubMed ID: 10150326
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN, Sader HS, Fritsche TR, Pottumarthy S.
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Gram-negative bacillary meningitis. New therapy and changing concepts.
    Landesman SH, Cherubin CE, Corrado ML.
    Arch Intern Med; 1982 May; 142(5):939-40. PubMed ID: 6211153
    [Abstract] [Full Text] [Related]

  • 17. [In vitro antibacterial activity of eight third generation cephalosporins (author's transl)].
    Deforges L, Le Van Thoi J, Soussy CJ, Duval J.
    Pathol Biol (Paris); 1982 Jun; 30(6):363-9. PubMed ID: 6810282
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cefepime: a new fourth-generation cephalosporin.
    Okamoto MP, Nakahiro RK, Chin A, Bedikian A, Gill MA.
    Am J Hosp Pharm; 1994 Feb 15; 51(4):463-77; quiz 541-2. PubMed ID: 8017411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.